This country profile provides an overview of Senegal’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
6.16 million people received treatment in Senegal in 2019 2.66 million people did not receive treatment in Senegal in 2019
Treatment coverage increased from 62% in 2018 to 68% in 2019.
People needing treatment8.82m
People receiving treatment6.01m
Senegal is conducting post-preventive chemotherapy surveillance.
Treatment coverage increased from 34% in 2018 to 70% in 2019.
Pre-sch and school-aged children needing treatment1.08m
Pre-school and school-aged children receiving treatment758k
Treatment coverage increased from 67% in 2018 to 76% in 2019.
School-aged children needing treatment1.92m
School-aged children receiving treatment1.46m
Treatment coverage decreased from 94% in 2018 to 26% in 2019.
People needing treatment723k
People receiving treatment190k
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Senegal.